0000797564 --12-31 true true false false false 2023 Q2 true false 0000797564 2023-01-01 2023-06-30 0000797564 2023-06-30 0000797564 2023-08-11 0000797564 2022-12-31 0000797564 2023-04-01 2023-06-30 0000797564 2022-04-01 2022-06-30 0000797564 2022-01-01 2022-06-30 0000797564 2021-12-31 0000797564 us-gaap:CommonStockMember 2021-12-31 0000797564 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000797564 us-gaap:RetainedEarningsMember 2021-12-31 0000797564 us-gaap:ParentMember 2021-12-31 0000797564 us-gaap:CommonStockMember 2022-01-01 2022-03-30 0000797564 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-30 0000797564 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-30 0000797564 us-gaap:ParentMember 2022-01-01 2022-03-30 0000797564 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000797564 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000797564 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000797564 us-gaap:ParentMember 2022-04-01 2022-06-30 0000797564 2022-06-30 0000797564 us-gaap:CommonStockMember 2022-06-30 0000797564 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000797564 us-gaap:RetainedEarningsMember 2022-06-30 0000797564 us-gaap:ParentMember 2022-06-30 0000797564 us-gaap:CommonStockMember 2022-12-31 0000797564 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000797564 us-gaap:RetainedEarningsMember 2022-12-31 0000797564 us-gaap:ParentMember 2022-12-31 0000797564 us-gaap:CommonStockMember 2023-01-01 2023-03-30 0000797564 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-30 0000797564 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-30 0000797564 us-gaap:ParentMember 2023-01-01 2023-03-30 0000797564 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000797564 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000797564 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000797564 us-gaap:ParentMember 2023-04-01 2023-06-30 0000797564 us-gaap:CommonStockMember 2023-06-30 0000797564 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000797564 us-gaap:RetainedEarningsMember 2023-06-30 0000797564 us-gaap:ParentMember 2023-06-30 0000797564 fil:NotesPayableRelatedPartiesMember 2023-01-01 2023-06-30 0000797564 fil:ExecutiveOfficesMember 2023-01-01 2023-06-30 0000797564 fil:HowellConsultingAgreementMember 2023-01-01 2023-06-30 0000797564 fil:HowellConsultingAgreementMember 2022-12-31 0000797564 fil:HowellConsultingAgreementMember 2023-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[x]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended

June 30, 2023

or

[  ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

For the transition period from

 

to

 

 

Commission file number 000-15303

 

HST Global, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

73-1215433

(State or other jurisdiction of incorporation or organization)

(I. R. S. Employer Identification No.)

 

 

150 Research Drive, Hampton, VA

23666

(Address of principal executive offices)

(Zip Code)

 

757-766-6100

(Registrant’s telephone number, including area code)

 

n/a

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

 

None

 

 

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 

Yes [x]  No [  ]

Page 1

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [x]  No [  ] 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  [  ]

Accelerated filer  [  ]

Non-accelerated filer  [x]

Smaller reporting company  [x]

 

Emerging growth Company [x]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

[  ]

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act).

Yes [  ]   No [x] 

The number of shares of the registrant’s common stock outstanding as of August 11, 2023 was

5,248,582 shares

Page 2

TABLE OF CONTENTS

PART I

FINANCIAL INFORMATION

4

Item 1. 

Financial Statements

4

 

Condensed Balance Sheets (unaudited)

4

 

Condensed Statements of Operations (unaudited)

5

 

Condensed Statements of Stockholders’ Deficit (unaudited)

6

 

Condensed Statements of Cash Flow (unaudited)

7

 

Notes to Condensed Financial Statements (unaudited)

8

Item 2.

Management’s Discussion and Analysis of Financial Conditions and Results of Operations

11

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

12

Item 4.

Controls and Procedures

12

PART II

OTHER INFORMATION

13

Item 1.

Legal Proceedings

13

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

13

Item 3.

Default Upon Senior Securities

13

Item 4.

Mine Safety Disclosures

13

Item 5.

Other Information

13

Item 6.

Exhibits

13

Signatures

 

13

Page 3

PART I – FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

 

HST GLOBAL, INC.

Condensed Balance Sheets

 

June 30,
2023

 

December 31,
2022

 

(Unaudited)  

 

(Unaudited)

ASSETS

 

 

 

 

 

 

 

Current Assets

 

 

 

Cash and cash equivalents

$2,320  

 

$190  

 

Total Current Assets

2,320  

 

190  

 

Total Assets

$2,320  

 

$190  

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

Current Liabilities

 

 

 

Accounts payable and accrued expenses

$-  

 

$-  

Accounts payable and accrued expenses - related parties

422,275  

 

362,275  

Loans or advances from related party

89,271  

 

76,077  

Accrued related party interest

10,212  

 

7,695  

 

Total Current Liabilities

521,758  

 

446,047  

 

Total Liabilities

521,758  

 

446,047  

 

 

 

 

Stockholders' Deficit

 

 

 

Preferred stock; 10,000,000 shares authorized,
at $0.001 par value, 0 shares issued and
outstanding at June 30, 2023 and December 31, 2022

-  

 

-  

Common stock; 200,000,000 shares
authorized, at $0.001 par value, 5,248,582
shares issued and outstanding at June 30,2023
and December 31, 2022

5,248  

 

5,248  

Additional paid-in capital

5,417,236  

 

5,417,236  

Accumulated deficit

(5,941,922) 

 

(5,868,341) 

Total Stockholders' Deficit

(519,438) 

 

(445,857) 

Total Liabilities and Stockholders' Deficit

$2,320  

 

$190  

The accompanying notes are an integral part of these unaudited condensed financial statements

Page 4

HST GLOBAL, INC.

Condensed Statements of Operations

(Unaudited)

 

For the Three Months

Ended June 30, 2023

 

For the Three Months

Ended June 30, 2022

 

For the Six Months

Ended June 30, 2023

 

For the Six Months

Ended June 30, 2022

REVENUES

$-  

 

$-  

 

$-  

 

$-  

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

Consulting, related party

30,000  

 

30,000  

 

60,000  

 

60,000  

General and administrative

2,990  

 

4,527  

 

11,065  

 

11,860  

 

 

 

 

 

 

 

 

Total Operating Expenses

32,990  

 

34,527  

 

71,065  

 

71,860  

 

 

 

 

 

 

 

 

Loss from Operations

(32,990) 

 

(34,527) 

 

(71,065) 

 

(71,860) 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

(1,305) 

 

(986) 

 

(2,516) 

 

(1,867) 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

(1,305) 

 

(986) 

 

(2,516) 

 

(1,867) 

 

 

 

 

 

 

 

 

Loss Before Income Taxes

(34,295) 

 

(35,513) 

 

(73,581) 

 

(73,727) 

Provision for Income Taxes

-  

 

-  

 

-  

 

-  

NET LOSS

$(34,295) 

 

$(35,513) 

 

$(73,581) 

 

$(73,727) 

 

 

 

 

 

 

 

 

Basic and Diluted Loss Per Share

$(0.01) 

 

$(0.01) 

 

$(0.01) 

 

$(0.01) 

 

 

 

 

 

 

 

 

Basic and Diluted Weighted Average
Number of Common Shares Outstanding

5,248,582  

 

5,248,582  

 

5,248,582  

 

5,248,582  

 

The accompanying notes are an integral part of these unaudited condensed financial statements

Page 5

HST Global, Inc.

Condensed Statements of Stockholders’ Deficit
(Unaudited)

Preferred Stock

Common Stock

Additional Paid-in

Accumulated

Total Stockholder’s

 

Shares

Amount

Shares

Amount

Capital

Deficit

Deficit

 

 

 

 

 

 

 

 

Balance, December 31, 2021

- 

$- 

5,248,582 

$5,248 

$5,417,236 

$(5,723,267) 

$(300,783) 

Net loss

- 

- 

- 

- 

- 

(38,214) 

(38,214) 

Balance, March 31, 2022

- 

- 

5,248,582 

5,248 

5,417,236 

(5,761,481) 

(338,997) 

Net loss

- 

- 

- 

- 

- 

(35,513) 

(35,513) 

Balance, June 30, 2022

- 

$- 

5,248,582 

$5,248 

$5,417,236 

$(5,796,994) 

$(374,510) 

 

 

 

 

 

 

 

 

Balance, December 31, 2022

- 

$- 

5,248,582 

$5,248 

$5,417,236 

$(5,868,341) 

$(445,857) 

Net loss

- 

- 

- 

- 

- 

(39,286) 

(39,286) 

Balance, March 31, 2023

- 

- 

5,248,582 

5,248 

5,417,236 

(5,907,627) 

(485,143) 

Net loss

- 

- 

- 

- 

- 

(34,295) 

(34,295) 

Balance, June 30, 2023

- 

$- 

5,248,582 

$5,248 

$5,417,236 

$(5,941,922) 

$(519,438) 

The accompanying notes are an integral part of these unaudited condensed financial statements

Page 6

HST GLOBAL, INC.

Condensed Statements of Cash Flows

(Unaudited)

 

For the Six Months Ended

June 30,2023

 

For the Six Months Ended

June 30, 2022

Operating Activities

 

 

 

Net loss

$(73,581) 

 

$(73,727) 

Adjustments to reconcile net loss to net cash
used in operating activities:

 

 

 

Changes in operating assets and liabilities:

 

 

 

Accounts payable and accrued expenses

-  

 

- 

Accounts payable and accrued expenses-related parties

60,000  

 

60,800  

Accrued related party interest

2,517  

 

1,867  

Net Cash Used in Operating Activities

(11,064) 

 

(11,860) 

 

 

 

 

Investing Activities

 

 

 

Net Cash Used in Investing Activities

-  

 

-  

 

 

 

 

Financing Activities

 

 

 

Proceeds from loans or advances from related party

13,194  

 

12,000  

Net Cash Provided by Financing Activities

13,194  

 

12,000  

 

 

 

 

Net Change in Cash and Cash Equivalents

2,130 

 

140 

 

 

 

 

Cash and Cash Equivalents at Beginning of Period

190  

 

225 

 

 

 

 

Cash and Cash Equivalents at End of Period

$2,320  

 

$365  

 

 

 

 

Supplemental Disclosures of Cash Flow Information:

 

 

 

Cash paid for interest

$-  

 

$-  

Cash paid for taxes

$-  

 

$-  

The accompanying notes are an integral part of these unaudited condensed financial statements

Page 7

HST GLOBAL, INC.

Notes to Condensed Financial Statements (Unaudited)

June 30, 2023

NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES

HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition was accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations.  Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.

The Company was founded as an Integrated Health and Wellness Biotechnology company with a plan to develop and /or acquire a network of Wellness Centers worldwide that would be primarily focused on the homeopathic and alternative treatment of late stage cancer.

To date we have been unable to initiate our original business plan.  While we are continuing to seek opportunities to do so, we are also seeking other opportunities to integrate assets, rights, or other potential revenue streams.

The accompanying interim condensed financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnotes necessary for a complete presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. The unaudited quarterly condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K of the Company as of and for the fiscal year ended December 31, 2022. The results of operations for the period ended June 30, 2023, are not necessarily indicative of the results for a full-year period.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the SEC to Form 10-K and 10-Q.  

Accounting Method

The Company’s condensed financial statements are prepared using the accrual method of accounting.  The Company has elected a December 31 year-end.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Page 8

Cash and Cash Equivalents

We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

Basic and Diluted Income (Loss) Per Share

The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260, “Earnings Per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

Stock-Based Compensation

The Company adopted ASC 718, “Stock Compensation”. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based on their fair values. As of June 30, 2023, the Company has not issued any employer stock options.

Fair Value of Financial Instruments

The Company adopted ASC 820, “Fair Value Measurement”, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.

The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis.

Recently Issued Accounting Pronouncements

Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed financial statements.

NOTE 3 – GOING CONCERN

The Company’s condensed financial statements are prepared using U.S. GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern for a period of one year from the issuance of these financial statements. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.  These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.

Page 9

Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the funds it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying condensed financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

NOTE 4 – RELATED PARTY TRANSACTIONS

Loans or Advances from Related Party

During the six months ended June 30, 2023, the Company received $13,184 in additional cash loans from Ronald R. Howell. As of June 30, 2023, the Company owed Mr. Howell $89,271.47 in notes payable.

Executive Offices

The Company’s executive offices are located at 150 Research Dr., Hampton VA.  These offices are leased by The Health Network, Inc. (“THN”), of which Ron Howell is President.  THN allows the Company to use the office space without a formal sublease or rental agreement.

Consulting Agreements

The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010.  The Company had agreed to continue to engage Mr. Howell as a consultant until his consulting services are no longer required.  As of December 31, 2022, the Company owed Mr. Howell $360,000 under the consulting agreement.  As of June 30, 2023, the Company owed Mr. Howell $420,000 under the consulting agreement.

 

NOTE 5 – SUBSEQUENT EVENTS

In accordance with ASC 855, “Subsequent Events”, Company management reviewed all material events and transactions through the date of this report and determined that there are no other subsequent events to record or report.

 

Page 10

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the information contained in the condensed financial statements of the Company and the notes thereto appearing elsewhere herein.  As used in this report, the terms "Company", "we", "our", "us" and "HSTC" refer to HST Global, Inc.

Preliminary Note Regarding Forward-Looking Statements

This quarterly report contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as "anticipate," "expect," "intend," "plan," "will," "we believe," "HSTC believes," "management believes" and similar language. The forward-looking statements are based on the current expectations of HSTC and are subject to certain risks, uncertainties and assumptions, including those set forth in the discussion under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this report. The actual results may differ materially from results anticipated in these forward-looking statements. We base the forward-looking statements on information currently available to us, and we assume no obligation to update them.  Investors are also advised to refer to the information in our filings with the Securities and Exchange Commission, especially on Forms 10-K, 10-Q and 8-K, in which we discuss in more detail various important factors that could cause actual results to differ from expected or historic results. It is not possible to foresee or identify all such factors. As such, investors should not consider any list of such factors to be an exhaustive statement of all risks and uncertainties or potentially inaccurate assumptions.

Critical Accounting Policies and Estimates

Our financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States ("US GAAP"). US GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenues and expense amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.

Results of Operations – The Three Months Ended June 30, 2023 as Compared to the Three Months Ended June 30, 2022

The Company had no revenues or costs of sales during 2023 or 2022. The Company realized a net loss of $34,295 for the quarter ended June 30, 2023 as compared to a net loss of $35,513 for the quarter ended June 30, 2022. The decrease in net loss of $1,218 for the 2nd quarter of 2023 is attributable to a decrease in G&A expenses offset by a slight increase in interest expense.  

Results of Operations – The Six Months Ended June 30, 2023 as Compared to the Six Months Ended June 30, 2022

The Company had no revenues or costs of sales for the six-month period ended June 30, 2023 or 2022. The Company incurred net loss of $73,581 for the six months ended June 30, 2023 as compared to a net loss of $73,727 for the six months ended June 30, 2022.  The yearly operating expenses as of the second quarters of 2023 were $71,065 versus $71,860 for the same period in 2022.  The decrease was based on the decrease in G&A expenses.

Page 11

Liquidity and Capital Resources

Operating Activities.  

Our cash balance as of June 30, 2023 was $2,320, with a cash balance of $365 on June 30, 2022.

Financing Activities.

The Company has paid for its operations through proceeds of $12,000 during 2022 from loans or advances from related parties. In the six months ended June 30, 2023 the Company received funds in the form of loans or advances from related parties in an amount of $13,194.

The Company does not currently have sufficient capital in its accounts, nor sufficient firm commitments for capital to assure its ability to meet its current obligations or to continue its planned operations. The Company is continuing to pursue working capital and additional revenue through the seeking of the capital it needs to carry on its planned operations. There is no assurance that any of the planned activities will be successful.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

None.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Interim Chief Financial Officer (the "Certifying Officer") maintains a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management timely. Under the supervision and with the participation of management, the Certifying Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule [13a-14(c)/15d-14(c)] under the Exchange Act) within 45 days prior to the filing date of this report. Based upon that evaluation, the Certifying Officer concluded that our disclosure controls and procedures are not effective in timely alerting them to material information relative to our company required to be disclosed in our periodic filings with the SEC.

Changes in Internal Controls

During the quarter ended June 30, 2023, there were no changes made to our internal controls over financial reporting that are reasonably likely to affect the reliability of those controls, or the accuracy of our financial reporting.  

Page 12

PART II: OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

None.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.  MINE SAFETY DISCLOSURES

None.

ITEM 5.  OTHER INFORMATION

None.

ITEM 6.  EXHIBITS

The following exhibits are filed as part of this quarterly report on Form 10-Q:

Exhibit No.

 

Description

31.1

 

Certification by the Chief Executive Officer of Competitive Technologies, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).

31.2

 

Certification by the Chief Financial Officer of Competitive Technologies, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).

32.1

 

Certification by the Chief Executive Officer of Competitive Technologies, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

32.2

 

Certification by the Chief Financial Officer of Competitive Technologies, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

101

 

Interactive Data Files

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: July 31, 2023

 

HST GLOBAL, INC.

 

 

(the registrant)

 

 

 

 

 

By:

s Ron Howell

 

 

Ron Howell

 

 

Chief Executive Officer

 

 

Interim Chief Financial Officer

Page 13

Exhibit 31.1

 

CERTIFICATIONS

 

I, Ron Howell certify that:

 

1.I have reviewed this Report on Form 10-Q of HST Global, Inc. (the “Company”) for the period ending June 30, 2023; 

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 

 

4.I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have: 

 

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

 

(c)evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

(d)disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter (the Company’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 

 

5.I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s Board of Directors (or persons performing the equivalent functions): 

 

(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and 

 

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. 

 

Dated: August 11, 2023

 

By:

s Ron Howell

 

 

Ron Howell

 

 

Chief Executive Officer

 

Exhibit 31.2

 

CERTIFICATIONS

 

I, Ron Howell, certify that:

 

1.I have reviewed this Report on Form 10-Q of HST Global, Inc. (the “Company”) for the period ending June 30, 2023; 

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 

 

4.I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have: 

 

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

 

(c)evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

(d)disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter (the Company’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 

 

5.I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s Board of Directors (or persons performing the equivalent functions): 

 

(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and 

 

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. 

 

Dated: August 11, 2023

 

By:

s Ron Howell

 

 

Ron Howell

 

 

Interim Chief Financial Officer

 

Exhibit 32.1

 

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. 1350)

 

 

In connection with the Report of HST Global, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ron Howell, Chief Executive Officer and Chairman of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), that to my knowledge: 

 

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

 

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

 

Dated: August 11, 2023

 

By:

s Ron Howell

 

 

Ron Howell

 

 

Chief Executive Officer

 

Exhibit 32.2

 

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. 1350)

 

 

In connection with the Report of HST Global, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ron Howell, Interim Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), that to my knowledge: 

 

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

 

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

 

Dated: August 11, 2023

 

By:

s Ron Howell

 

 

Ron Howell

 

 

Interim Chief Financial Officer

 

 

v3.23.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2023
Aug. 11, 2023
Details    
Registrant CIK 0000797564  
Fiscal Year End --12-31  
Entity Emerging Growth Company true  
Entity Small Business true  
Entity Ex Transition Period false  
Entity Shell Company false  
Document Type 10-Q  
Document Period End Date Jun. 30, 2023  
Entity File Number 000-15303  
Entity Registrant Name HST Global, Inc.  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 73-1215433  
Entity Address, Address Line One 150 Research Drive  
Entity Address, City or Town Hampton  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 23666  
City Area Code 757  
Local Phone Number 766-6100  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   5,248,582
Amendment Flag false  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Document Quarterly Report true  
Document Transition Report false  
v3.23.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 2,320 $ 190
Total Current Assets 2,320 190
Total Assets 2,320 190
Current Liabilities    
Accounts payable and accrued expenses 0 0
Accounts payable and accrued expenses - related parties 422,275 362,275
Loans or advances from related party 89,271 76,077
Accrued related party interest 10,212 7,695
Total Current Liabilities 521,758 446,047
Total Liabilities 521,758 446,047
Stockholders' Deficit    
Preferred stock; 10,000,000 shares authorized, at $0.001 par value, 0 shares issued and outstanding at June 30, 2023 and December 31, 2022 0 0
Common stock; 200,000,000 shares authorized, at $0.001 par value, 5,248,582 shares issued and outstanding at June 30,2023 and December 31, 2022 5,248 5,248
Additional paid-in capital 5,417,236 5,417,236
Accumulated deficit (5,941,922) (5,868,341)
Total Stockholders' Deficit (519,438) (445,857)
Total Liabilities and Stockholders' Deficit $ 2,320 $ 190
v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Condensed Consolidated Statements of Operations        
REVENUES $ 0 $ 0 $ 0 $ 0
OPERATING EXPENSES        
Consulting, related party 30,000 30,000 60,000 60,000
General and administrative 2,990 4,527 11,065 11,860
Total Operating Expenses 32,990 34,527 71,065 71,860
Loss from Operations (32,990) (34,527) (71,065) (71,860)
OTHER INCOME (EXPENSE)        
Interest expense 1,305 986 2,516 1,867
Total Other Income (Expense) (1,305) (986) (2,516) (1,867)
Loss Before Income Taxes (34,295) (35,513) (73,581) (73,727)
Provision for Income Taxes 0 0 0 0
NET LOSS $ (34,295) $ (35,513) $ (73,581) $ (73,727)
Basic and Diluted Loss Per Share $ (0.01) $ (0.01) $ (0.01) $ (0.01)
Basic and Diluted Weighted Average Number of Common Shares Outstanding 5,248,582 5,248,582 5,248,582 5,248,582
v3.23.2
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
 3 Months Ended
Mar. 30, 2022
Mar. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Common Stock        
Balance, December 31, 2021     $ 5,248 $ 5,248
Net loss $ 0 $ 0 0 0
Balance, June 30, 2022     5,248 5,248
Balance, December 31, 2022 5,248 5,248    
Balance, June 30, 2023     5,248 5,248
Additional Paid-in Capital        
Balance, December 31, 2021     5,417,236 5,417,236
Net loss 0 0 0 0
Balance, June 30, 2022     5,417,236 5,417,236
Balance, December 31, 2022 5,417,236 5,417,236    
Balance, June 30, 2023     5,417,236 5,417,236
Retained Earnings        
Balance, December 31, 2021     (5,941,922) (5,796,994)
Net loss (38,214) (39,286) (34,295) (35,513)
Balance, June 30, 2022     (5,941,922) (5,796,994)
Balance, December 31, 2022 (5,723,267) (5,868,341)    
Balance, June 30, 2023     (5,941,922) (5,796,994)
Parent        
Balance, December 31, 2021     (519,438) (374,510)
Net loss (38,214) (39,286) (34,295) (35,513)
Balance, June 30, 2022     (519,438) (374,510)
Balance, December 31, 2022 $ (300,783) $ (445,857)    
Balance, June 30, 2023     $ (519,438) $ (374,510)
v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities    
Net loss $ (73,581) $ (73,727)
Changes in operating assets and liabilities    
Accounts payable and accrued expenses 0 0
Accounts payable and accrued expenses-related parties 60,000 60,800
Accrued related party interest 2,517 1,867
Net Cash Used in Operating Activities (11,064) (11,860)
Investing Activities    
Net Cash Used in Investing Activities 0 0
Financing Activities    
Proceeds from loans or advances from related party 13,194 12,000
Net Cash Provided by Financing Activities 13,194 12,000
Net Change in Cash and Cash Equivalents 2,130 140
Cash and Cash Equivalents at Beginning of Period 190 225
Cash and Cash Equivalents at End of Period 2,320 365
Cash paid for interest 0 0
Cash paid for taxes $ 0 $ 0
v3.23.2
NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES
 6 Months Ended
Jun. 30, 2023
Notes  
NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES

NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES

HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition was accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations.  Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.

The Company was founded as an Integrated Health and Wellness Biotechnology company with a plan to develop and /or acquire a network of Wellness Centers worldwide that would be primarily focused on the homeopathic and alternative treatment of late stage cancer.

To date we have been unable to initiate our original business plan.  While we are continuing to seek opportunities to do so, we are also seeking other opportunities to integrate assets, rights, or other potential revenue streams.

The accompanying interim condensed financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnotes necessary for a complete presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. The unaudited quarterly condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K of the Company as of and for the fiscal year ended December 31, 2022. The results of operations for the period ended June 30, 2023, are not necessarily indicative of the results for a full-year period.
v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Jun. 30, 2023
Notes  
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the SEC to Form 10-K and 10-Q.  

Accounting Method

The Company’s condensed financial statements are prepared using the accrual method of accounting.  The Company has elected a December 31 year-end.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

Basic and Diluted Income (Loss) Per Share

The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260, “Earnings Per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

Stock-Based Compensation

The Company adopted ASC 718, “Stock Compensation”. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based on their fair values. As of June 30, 2023, the Company has not issued any employer stock options.

Fair Value of Financial Instruments

The Company adopted ASC 820, “Fair Value Measurement”, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.

The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis.

Recently Issued Accounting Pronouncements

Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed financial statements.
v3.23.2
NOTE 3 - GOING CONCERN
 6 Months Ended
Jun. 30, 2023
Notes  
NOTE 3 - GOING CONCERN

NOTE 3 – GOING CONCERN

The Company’s condensed financial statements are prepared using U.S. GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern for a period of one year from the issuance of these financial statements. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.  These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.

Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the funds it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying condensed financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
v3.23.2
NOTE 4 - RELATED PARTY TRANSACTIONS
 6 Months Ended
Jun. 30, 2023
Notes  
NOTE 4 - RELATED PARTY TRANSACTIONS

NOTE 4 – RELATED PARTY TRANSACTIONS

Loans or Advances from Related Party

During the six months ended June 30, 2023, the Company received $13,184 in additional cash loans from Ronald R. Howell. As of June 30, 2023, the Company owed Mr. Howell $89,271.47 in notes payable.

Executive Offices

The Company’s executive offices are located at 150 Research Dr., Hampton VA.  These offices are leased by The Health Network, Inc. (“THN”), of which Ron Howell is President.  THN allows the Company to use the office space without a formal sublease or rental agreement.

Consulting Agreements

The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010.  The Company had agreed to continue to engage Mr. Howell as a consultant until his consulting services are no longer required.  As of December 31, 2022, the Company owed Mr. Howell $360,000 under the consulting agreement.  As of June 30, 2023, the Company owed Mr. Howell $420,000 under the consulting agreement.
v3.23.2
NOTE 5 - SUBSEQUENT EVENTS
 6 Months Ended
Jun. 30, 2023
Notes  
NOTE 5 - SUBSEQUENT EVENTS

NOTE 5 – SUBSEQUENT EVENTS

In accordance with ASC 855, “Subsequent Events”, Company management reviewed all material events and transactions through the date of this report and determined that there are no other subsequent events to record or report.

 
v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basis of Presentation (Policies)
 6 Months Ended
Jun. 30, 2023
Policies  
Basis of Presentation

Basis of Presentation

The accompanying condensed financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the SEC to Form 10-K and 10-Q.  
v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Accounting Method (Policies)
 6 Months Ended
Jun. 30, 2023
Policies  
Accounting Method

Accounting Method

The Company’s condensed financial statements are prepared using the accrual method of accounting.  The Company has elected a December 31 year-end.
v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Use of Estimates (Policies)
 6 Months Ended
Jun. 30, 2023
Policies  
Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Cash and Cash Equivalents (Policies)
 6 Months Ended
Jun. 30, 2023
Policies  
Cash and Cash Equivalents

Cash and Cash Equivalents

We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.
v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basic and Diluted Income (Loss) Per Share (Policies)
 6 Months Ended
Jun. 30, 2023
Policies  
Basic and Diluted Income (Loss) Per Share

Basic and Diluted Income (Loss) Per Share

The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260, “Earnings Per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Stock-Based Compensation (Policies)
 6 Months Ended
Jun. 30, 2023
Policies  
Stock-Based Compensation

Stock-Based Compensation

The Company adopted ASC 718, “Stock Compensation”. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based on their fair values. As of June 30, 2023, the Company has not issued any employer stock options.
v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Fair Value of Financial Instruments (Policies)
 6 Months Ended
Jun. 30, 2023
Policies  
Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Company adopted ASC 820, “Fair Value Measurement”, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.

The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis.

v3.23.2
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Recently Issued Accounting Pronouncements (Policies)
 6 Months Ended
Jun. 30, 2023
Policies  
Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed financial statements.
v3.23.2
NOTE 4 - RELATED PARTY TRANSACTIONS (Details) - USD ($)
 6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Loans or advances from related party $ 89,271 $ 76,077
Notes Payable - Related Parties    
Related Party Transaction, Description of Transaction During the six months ended June 30, 2023, the Company received $13,184 in additional cash loans from Ronald R. Howell. As of June 30, 2023, the Company owed Mr. Howell $89,271.47 in notes payable.  
Increase (Decrease) in Due to Related Parties $ 13,184  
Executive Offices    
Related Party Transaction, Description of Transaction THN allows the Company to use the office space without a formal sublease or rental agreement.  
Howell Consulting Agreement    
Related Party Transaction, Description of Transaction The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services  
Loans or advances from related party $ 420,000 $ 360,000
HST Global (PK) (USOTC:HSTC)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 HST Global (PK) 차트를 더 보려면 여기를 클릭.